Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2020

Open Access 01-12-2020 | CT Angiography | Research article

Assessment of high sensitivity C-reactive protein and coronary plaque characteristics by computed tomography in patients with and without diabetes mellitus

Authors: Hai-Ting Zhou, De-Li Zhao, Guo-Kun Wang, Tian-Zuo Wang, Hong-Wei Liang, Jin-Ling Zhang

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Login to get access

Abstract

Background

To evaluate the coronary plaque characteristics of coronary arteries using computed tomography angiography (CTA) in order to assess the risk of coronary artery disease and the relevance of high sensitivity C reactive protein (hs-CRP) in patients with Diabetes Mellitus (DM).

Methods

The clinical data of 400 DM patients and 400 non-DM patients from January 2017 to December 2019 were collected, including the results of coronaryCTA. The plasma hs-CRP level of the two groups were divided into three groups: CRP ≤ 1, 1 < CRP ≤ 2, CRP > 2. The correlation of the degree of stenosis, the number of plaques, the nature of plaques and hs-CRP value between the two groups was evaluated.

Results

Compared with non-DM patients, the incidence of coronary artery plaques and lumen stenosis in DM patients was more higher than that in non-DM patients. DM patients were more likely to have more diseased vessels, especially diffuse vascular disease (12.00% vs 1.75%; P < 0.001). Subjects with high hs-CRP levels were more likely to have any plaque compared with individuals showing normal hs-CRP levels (p<0.01). There was no statistical significance in non calcified plaque with high level of hs-CRP, but the occurrence of plaque types in DM group was statistically significant compared with other hs-CRP levels in non DM group. Subjects with high hs-CRP were observed to be at increased risk for the presence of calcified plaque and severe narrowing in the unadjusted values.

Conclusions

Coronary CTA combined with hs-CRP can accurately detect the characteristics of coronary artery stenosis and plaque in DM patients, which has an important clinical value in the risk assessment of coronary heart disease in DM patients.
Literature
1.
go back to reference Arnold SV, Spertus JA, Jones PG, et al. Predicting adverse outcomes after myocardial infarction among patients with diabetes mellitus. Circ Cardiovasc Qual Outcomes. 2016;9:372–9.PubMedPubMedCentralCrossRef Arnold SV, Spertus JA, Jones PG, et al. Predicting adverse outcomes after myocardial infarction among patients with diabetes mellitus. Circ Cardiovasc Qual Outcomes. 2016;9:372–9.PubMedPubMedCentralCrossRef
2.
3.
go back to reference Bauters C, Lemesle G. Screening for asymptomatic coronary artery disease in patients with diabetes mellitus: a systematic review and meta-analysis of randomized trials. BMC Cardiovasc Disord. 2016;16:90.PubMedPubMedCentralCrossRef Bauters C, Lemesle G. Screening for asymptomatic coronary artery disease in patients with diabetes mellitus: a systematic review and meta-analysis of randomized trials. BMC Cardiovasc Disord. 2016;16:90.PubMedPubMedCentralCrossRef
4.
go back to reference Kang SH, Park GM, Lee SW, et al. Long-term prognostic value of coronary CT angiography in asymptomatic type 2 diabetes mellitus. JACC Cardiovasc Imaging. 2016;9:1292–300.PubMedCrossRef Kang SH, Park GM, Lee SW, et al. Long-term prognostic value of coronary CT angiography in asymptomatic type 2 diabetes mellitus. JACC Cardiovasc Imaging. 2016;9:1292–300.PubMedCrossRef
5.
go back to reference Kerut EK, Hall ME, Turner MC, et al. Coronary risk assessment using traditional risk factors with CT coronary artery calcium scoring in clinical practice. Echocardiography. 2018;35(8):1216–22.PubMedCrossRef Kerut EK, Hall ME, Turner MC, et al. Coronary risk assessment using traditional risk factors with CT coronary artery calcium scoring in clinical practice. Echocardiography. 2018;35(8):1216–22.PubMedCrossRef
6.
go back to reference Hayek SS, Divers J, Raad M, et al. Predicting mortality in African Americans with type 2 diabetes mellitus: soluble Urokinase plasminogen activator receptor, coronary artery calcium, and high sensitivity C-reactive protein. J Am Heart Assoc. 2018;7(9):e008194.PubMedPubMedCentralCrossRef Hayek SS, Divers J, Raad M, et al. Predicting mortality in African Americans with type 2 diabetes mellitus: soluble Urokinase plasminogen activator receptor, coronary artery calcium, and high sensitivity C-reactive protein. J Am Heart Assoc. 2018;7(9):e008194.PubMedPubMedCentralCrossRef
7.
go back to reference Kaptoge S, Di Angelantonio E, Lowe G, et al. Emerging risk factors collaboration C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132–40.PubMedCrossRef Kaptoge S, Di Angelantonio E, Lowe G, et al. Emerging risk factors collaboration C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132–40.PubMedCrossRef
8.
go back to reference Qasim AN, Budharaju V, Mehta NN, et al. Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes. Clin Endocrinol. 2011;74:44–50.CrossRef Qasim AN, Budharaju V, Mehta NN, et al. Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes. Clin Endocrinol. 2011;74:44–50.CrossRef
9.
go back to reference Schroeder S, Kopp AF, Baumbach A, et al. Non-invasive characterisation of coronary lesion morphology by multi-slice computed tomography: a promising new technology for risk stratification of patients with coronary artery disease. Heart. 2001;85(5):576–8.PubMedPubMedCentralCrossRef Schroeder S, Kopp AF, Baumbach A, et al. Non-invasive characterisation of coronary lesion morphology by multi-slice computed tomography: a promising new technology for risk stratification of patients with coronary artery disease. Heart. 2001;85(5):576–8.PubMedPubMedCentralCrossRef
10.
go back to reference Wei-Wei CHEN, Run-Lin GAO, Li-Sheng LIU, et al. China cardiovascular diseases report 2015: a summary. J Geriatr Cardiol. 2017;14(1):1–10. Wei-Wei CHEN, Run-Lin GAO, Li-Sheng LIU, et al. China cardiovascular diseases report 2015: a summary. J Geriatr Cardiol. 2017;14(1):1–10.
11.
go back to reference Seferovic JP, Bentley-Lewis R, Claggett B, et al. Retinopathy, neuropathy, and subsequent cardiovascular events in patients with type 2 diabetes and acute coronary syndrome in the ELIXA: the importance of disease duration. J Diabetes Res. 2018;2018:1631263.PubMedPubMedCentralCrossRef Seferovic JP, Bentley-Lewis R, Claggett B, et al. Retinopathy, neuropathy, and subsequent cardiovascular events in patients with type 2 diabetes and acute coronary syndrome in the ELIXA: the importance of disease duration. J Diabetes Res. 2018;2018:1631263.PubMedPubMedCentralCrossRef
12.
go back to reference Moon JS, Yoon JS, Won KC, et al. Diagnostic accuracy of 64-slice MDCT coronary angiography for the assessment of coronary artery disease in Korean patients with type 2 diabetes. Diabetes Metab J. 2013;37(1):54–62.PubMedPubMedCentralCrossRef Moon JS, Yoon JS, Won KC, et al. Diagnostic accuracy of 64-slice MDCT coronary angiography for the assessment of coronary artery disease in Korean patients with type 2 diabetes. Diabetes Metab J. 2013;37(1):54–62.PubMedPubMedCentralCrossRef
13.
go back to reference Ulimoen GR, Ofstad AP, Endresen K, et al. Low-dose CT coronary angiography for assessment of coronary artery disease in patients with type 2 diabetes - a cross-sectional study. BMC Cardiovasc Disord. 2015;15:147–53.PubMedPubMedCentralCrossRef Ulimoen GR, Ofstad AP, Endresen K, et al. Low-dose CT coronary angiography for assessment of coronary artery disease in patients with type 2 diabetes - a cross-sectional study. BMC Cardiovasc Disord. 2015;15:147–53.PubMedPubMedCentralCrossRef
14.
go back to reference Porter CJ, Stavroulopoulos A, Roe SD, et al. Detection of coronary and peripheral artery calcification in patients with chronic kidney disease stages 3 and 4, with and without diabetes. Nephrol Dial Transplant. 2007;22(11):3208–13.PubMedCrossRef Porter CJ, Stavroulopoulos A, Roe SD, et al. Detection of coronary and peripheral artery calcification in patients with chronic kidney disease stages 3 and 4, with and without diabetes. Nephrol Dial Transplant. 2007;22(11):3208–13.PubMedCrossRef
15.
go back to reference Sugiyama T, Yamamoto E, Bryniarski K, et al. Coronary plaque characteristics in patients with diabetes mellitus who presented with acute coronary syndromes. J Am Heart Assoc. 2018;7(14):e009245.PubMedPubMedCentralCrossRef Sugiyama T, Yamamoto E, Bryniarski K, et al. Coronary plaque characteristics in patients with diabetes mellitus who presented with acute coronary syndromes. J Am Heart Assoc. 2018;7(14):e009245.PubMedPubMedCentralCrossRef
16.
go back to reference Rana JS, Liu JY, Moffet HH, Jaffe M, Karter AJ. Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events. J Gen Intern Med. 2016;31:387–93.PubMedCrossRef Rana JS, Liu JY, Moffet HH, Jaffe M, Karter AJ. Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events. J Gen Intern Med. 2016;31:387–93.PubMedCrossRef
17.
go back to reference Tousoulis D, Oikonomou E, Economou EK, et al. Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J. 2016;37:1723–32.PubMedCrossRef Tousoulis D, Oikonomou E, Economou EK, et al. Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J. 2016;37:1723–32.PubMedCrossRef
18.
go back to reference Hung MY, Hsu KH, Hu WS, et al. Gender-specific prognosis and risk impact of C-reactive protein, hemoglobin and platelet in the development of coronary spasm. Int J Med Sci. 2013;10:255–64.PubMedPubMedCentralCrossRef Hung MY, Hsu KH, Hu WS, et al. Gender-specific prognosis and risk impact of C-reactive protein, hemoglobin and platelet in the development of coronary spasm. Int J Med Sci. 2013;10:255–64.PubMedPubMedCentralCrossRef
19.
go back to reference Kengne AP, Batty GD, Hamer M, et al. Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies. Diabetes Care. 2012;35:396–403.PubMedPubMedCentralCrossRef Kengne AP, Batty GD, Hamer M, et al. Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies. Diabetes Care. 2012;35:396–403.PubMedPubMedCentralCrossRef
20.
go back to reference Fonseca FAH, de Oliveira Izar MC. High-sensitivity C-reactive protein and cardiovascular disease across countries and ethnicities. Clinics. 2016;71(4):235–42.PubMedPubMedCentralCrossRef Fonseca FAH, de Oliveira Izar MC. High-sensitivity C-reactive protein and cardiovascular disease across countries and ethnicities. Clinics. 2016;71(4):235–42.PubMedPubMedCentralCrossRef
21.
go back to reference Ong KL, Tso AW, Xu A, et al. Evaluation of the combined use of adiponectin and C-reactive protein levels as biomarkers for predicting the deterioration in glycaemia after a median of 5.4 years. Diabetologia. 2011;54:2552–60.PubMedPubMedCentralCrossRef Ong KL, Tso AW, Xu A, et al. Evaluation of the combined use of adiponectin and C-reactive protein levels as biomarkers for predicting the deterioration in glycaemia after a median of 5.4 years. Diabetologia. 2011;54:2552–60.PubMedPubMedCentralCrossRef
22.
go back to reference Cox AJ, Agarwal SM, Herrington D, et al. C-reactive protein concentration predicts mortality in type 2 diabetes: the diabetes heart study. Diabet Med. 2012;29(6):767–70.PubMedPubMedCentralCrossRef Cox AJ, Agarwal SM, Herrington D, et al. C-reactive protein concentration predicts mortality in type 2 diabetes: the diabetes heart study. Diabet Med. 2012;29(6):767–70.PubMedPubMedCentralCrossRef
23.
go back to reference Sorensen MH, Gerke O, Eugen Olsen J, et al. Soluble urokinase plasminogen activator receptor is in contrast to high sensitive C reactive protein associated with coronary artery calcifications in healthy middle-aged subjects. Atherosclerosis. 2014;237:60–6.PubMedCrossRef Sorensen MH, Gerke O, Eugen Olsen J, et al. Soluble urokinase plasminogen activator receptor is in contrast to high sensitive C reactive protein associated with coronary artery calcifications in healthy middle-aged subjects. Atherosclerosis. 2014;237:60–6.PubMedCrossRef
24.
go back to reference Grammer TB, März W, Renner W, et al. C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study. Eur Heart J. 2009;30(2):170–82.PubMedCrossRef Grammer TB, März W, Renner W, et al. C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study. Eur Heart J. 2009;30(2):170–82.PubMedCrossRef
25.
go back to reference Anand SS, Yusuf S. C-reactive protein is a bystander of cardiovascular disease. Eur Heart J. 2010;31(17):2092–6.PubMedCrossRef Anand SS, Yusuf S. C-reactive protein is a bystander of cardiovascular disease. Eur Heart J. 2010;31(17):2092–6.PubMedCrossRef
26.
go back to reference Flores-Alfaro E, Fernández-Tilapa G, Salazar-Martínez E, et al. Common variants in the CRP gene are associated with serum C-reactive protein levels and body mass index in healthy individuals in Mexico. Genet Mol Res. 2012;11(3):2258–67.PubMedCrossRef Flores-Alfaro E, Fernández-Tilapa G, Salazar-Martínez E, et al. Common variants in the CRP gene are associated with serum C-reactive protein levels and body mass index in healthy individuals in Mexico. Genet Mol Res. 2012;11(3):2258–67.PubMedCrossRef
Metadata
Title
Assessment of high sensitivity C-reactive protein and coronary plaque characteristics by computed tomography in patients with and without diabetes mellitus
Authors
Hai-Ting Zhou
De-Li Zhao
Guo-Kun Wang
Tian-Zuo Wang
Hong-Wei Liang
Jin-Ling Zhang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01704-w

Other articles of this Issue 1/2020

BMC Cardiovascular Disorders 1/2020 Go to the issue